1. Home
  2. SKE vs IRTC Comparison

SKE vs IRTC Comparison

Compare SKE & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skeena Resources Limited

SKE

Skeena Resources Limited

HOLD

Current Price

$30.28

Market Cap

3.8B

ML Signal

HOLD

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

HOLD

Current Price

$114.33

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKE
IRTC
Founded
1979
2006
Country
Canada
United States
Employees
170
N/A
Industry
Precious Metals
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.9B
IPO Year
2017
2016

Fundamental Metrics

Financial Performance
Metric
SKE
IRTC
Price
$30.28
$114.33
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
$197.92
AVG Volume (30 Days)
509.1K
551.8K
Earning Date
05-12-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.71
EPS
N/A
N/A
Revenue
N/A
$747,138,000.00
Revenue This Year
N/A
$19.60
Revenue Next Year
$37,573.35
$15.94
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.24
52 Week Low
$13.12
$108.81
52 Week High
$38.77
$210.01

Technical Indicators

Market Signals
Indicator
SKE
IRTC
Relative Strength Index (RSI) 48.61 45.51
Support Level $28.14 $111.37
Resistance Level $34.86 $127.50
Average True Range (ATR) 1.46 5.66
MACD -0.15 -0.03
Stochastic Oscillator 33.43 38.49

Price Performance

Historical Comparison
SKE
IRTC

About SKE Skeena Resources Limited

Skeena Resources Ltd is a mining company in development stage focusing on the construction and development of the Eskay Creek project in British Columbia. Eskay Creek is the next global gold development project and represents one of the highest-grade and lowest-cost open-pit precious metals mines, with substantial silver by-product production.

About IRTC iRhythm Technologies Inc.

iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: